These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17036888)

  • 1. Pneumococcal vaccine and the new child vaccination schedule.
    Bedford H; Lane L
    Nurs Times; 2006 Sep 26-Oct 2; 102(39):44, 46-7. PubMed ID: 17036888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood immunisation (1): planned changes to the routine schedule.
    Diggle L
    Community Pract; 2006 Jul; 79(7):231-2. PubMed ID: 16878524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood immunisation: planned changes to the routine schedule (2).
    Diggle L
    Community Pract; 2006 Aug; 79(8):266-7. PubMed ID: 16922039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal immunisation in the 21st century.
    Williams C; Masterton R
    J Infect; 2008 Jan; 56(1):13-9. PubMed ID: 17980915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood vaccination update. A new weapon against pneumococcal bacteria.
    Waldrop TB
    Adv Nurse Pract; 2001 Feb; 9(2):34-6, 39. PubMed ID: 12416052
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.
    Palmu AA; Jokinen J; Borys D; Nieminen H; Ruokokoski E; Siira L; Puumalainen T; Lommel P; Hezareh M; Moreira M; Schuerman L; Kilpi TM
    Lancet; 2013 Jan; 381(9862):214-22. PubMed ID: 23158882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with pneumococcal conjugate vaccine in Norway.
    Aaberge IS
    Expert Rev Vaccines; 2009 Feb; 8(2):159-65. PubMed ID: 19196196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza and pneumococcal disease in the community.
    Riley C; Riley S
    Nurs Stand; 2003 Oct 8-14; 18(4):45-51; quiz 52, 55. PubMed ID: 14601214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric asthma and pneumococcal vaccination.
    Esposito S; Musio A; Principi N
    Vaccine; 2013 Oct; 31(44):5015-9. PubMed ID: 24021307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information from your family doctor. Pneumococcal conjugate vaccine: what a parent needs to know.
    Am Fam Physician; 2001 May; 63(10):2003-4. PubMed ID: 11388716
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants.
    Knuf M; Pankow-Culot H; Grunert D; Rapp M; Panzer F; Köllges R; Fanic A; Habib A; Borys D; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2012 Jan; 31(1):e31-6. PubMed ID: 21909049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
    Zoppi G; Trucchi C
    J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?
    Lu CY; Huang LM
    J Formos Med Assoc; 2011 Feb; 110(2):67-9. PubMed ID: 21377059
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
    Poolman J; Borrow R
    Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.